(Q52128036)

22 April 2018

title

Living with Marfan syndrome II. Medication adherence and physical activity modification. (English)

1 reference

22 April 2018

1 reference

Peters KF

1

1 reference

22 April 2018

Horne R

2

1 reference

22 April 2018

Kong F

3

1 reference

22 April 2018

Francomano CA

4

1 reference

22 April 2018

Biesecker BB

5

1 reference

22 April 2018

publication date

1 October 2001

1 reference

22 April 2018

published in

Clinical Genetics

1 reference

22 April 2018

volume

60

1 reference

22 April 2018

issue

4

1 reference

22 April 2018

page(s)

283-292

1 reference

22 April 2018

Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

Psychosocial adaptation in adolescents and young adults with Marfan syndrome: an exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

From Intentions to Actions: A Theory of Planned Behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

Living with Marfan syndrome I. Perceptions of the condition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

Genetic counseling for pregnant adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

Recall of Recommendations and Adherence to Advice Among Patients With Chronic Medical Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

Revised diagnostic criteria for the Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

7 January 2021

The Marfan syndrome locus: confirmation of assignment to chromosome 15 and identification of tightly linked markers at 15q15-q21.3.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

7 January 2021

Therapeutic management of patients with Marfan syndrome: focus on cardiovascular involvement

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

7 January 2021

Operative management of Marfan syndrome: The Johns Hopkins experience

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

7 January 2021

Survival and complication free survival in Marfan's syndrome: implications of current guidelines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

7 January 2021

Life expectancy in the Marfan syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

7 January 2021

Patients' beliefs about treatment: the hidden determinant of treatment outcome?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

7 January 2021

The meaning of medications: another look at compliance

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

7 January 2021

Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600406.X

7 January 2021

10.1034/J.1399-0004.2001.600406.X

Identifiers

DOI

1 reference

22 April 2018

PubMed ID

11683774

1 reference

22 April 2018